Abbott Laboratories (ABT) Goodwill (2009 - 2026)

Abbott Laboratories has disclosed Goodwill across 18 years of filings, most recently posting $35.2 billion for Q1 2026.

• Goodwill for Q1 2026 came in at $35.2 billion, up 50.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.2 billion (up 50.78% YoY), and the FY2025 annual result was $24.0 billion, up 4.05% from the prior year.
• Goodwill came in at $35.2 billion for Q1 2026 at Abbott Laboratories, up from $24.0 billion in the prior quarter.
• In the past five years, Goodwill ranged from a high of $35.2 billion in Q1 2026 to a low of $22.3 billion in Q3 2022.
• The 5-year median for Goodwill is $23.3 billion (2024), against an average of $24.0 billion.
• Across the five-year window, Goodwill decreased 4.29% in 2022 and jumped 50.78% in 2026, its largest moves.
• Abbott Laboratories' Goodwill stood at $22.8 billion in 2022, then advanced by 3.95% to $23.7 billion in 2023, then retreated by 2.53% to $23.1 billion in 2024, then increased by 4.05% to $24.0 billion in 2025, then jumped by 46.54% to $35.2 billion in 2026.
• The last three Goodwill figures came in at $35.2 billion (Q1 2026), $24.0 billion (Q4 2025), and $24.0 billion (Q3 2025), per Business Quant data.